Ching-Tai Huang Selected Research

Lymphedema (Milroy Disease)

1/2020

Clinical features, microbiological epidemiology and recommendations for management of cellulitis in extremity lymphedema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ching-Tai Huang Research Topics

Disease

16	Infections 01/2023 - 08/2005
13	Neoplasms (Cancer) 01/2023 - 05/2004
12	Pneumonia (Pneumonitis) 01/2023 - 11/2011
10	Human Influenza (Influenza) 01/2023 - 04/2012
5	Bacteremia 12/2018 - 08/2005
4	Inflammation (Inflammations) 01/2023 - 03/2012
4	COVID-19 12/2022 - 01/2020
4	Sepsis (Septicemia) 02/2019 - 05/2007
3	Thrombocytopenia (Thrombopenia) 10/2021 - 10/2008
3	Pneumococcal Infections 08/2021 - 06/2018
2	Meningitis 12/2020 - 08/2013
2	Fever (Fevers) 05/2016 - 10/2008
2	Colorectal Neoplasms (Colorectal Cancer) 10/2015 - 01/2014
1	Autoimmune Diseases (Autoimmune Disease) 02/2024
1	Pneumococcal Pneumonia 08/2021
1	Bacteriuria 12/2020
1	Critical Illness (Critically Ill) 12/2020
1	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 12/2020
1	Disease Resistance 12/2020
1	Thrombosis (Thrombus) 12/2020
1	Necrosis 01/2020
1	Cellulitis 01/2020
1	Lymphedema (Milroy Disease) 01/2020
1	Liver Failure 01/2020
1	Body Weight (Weight, Body) 11/2019
1	Healthcare-Associated Pneumonia 01/2019
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2018
1	Hepatitis 01/2018
1	Pleural Effusion (Pleural Effusions) 05/2016
1	Tularemia 05/2016
1	Reinfection 01/2016
1	Hepatocellular Carcinoma (Hepatoma) 10/2015

Drug/Important Bio-Agent (IBA)

8	Carbapenems (Carbapenem Antibiotics)IBA 12/2020 - 05/2014
6	AntigensIBA 01/2023 - 03/2005
5	Hemagglutinins (Hemagglutinin)IBA 01/2023 - 05/2004
5	Anti-Bacterial Agents (Antibiotics)IBA 03/2020 - 05/2014
4	CytokinesIBA 01/2023 - 04/2013
4	Neuraminidase (Sialidase)IBA 01/2023 - 03/2015
3	VaccinesIBA 12/2022 - 08/2021
3	Conjugate VaccinesIBA 08/2021 - 06/2018
3	Tigecycline (Tygacil)FDA Link 02/2019 - 11/2011
3	Sulbactam FDA LinkGeneric 01/2019 - 06/2015
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2022
2	Penicillins (Penicillin)FDA Link 01/2020 - 05/2014
2	Oseltamivir (Tamiflu)FDA Link 11/2019 - 01/2017
2	Cefepime (Maxipime)FDA LinkGeneric 01/2019 - 07/2017
2	Vancomycin FDA LinkGeneric 12/2018 - 03/2012
2	sultamicillin (ampicillin-sulbactam)FDA LinkGeneric 01/2016 - 06/2015
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2015 - 10/2015
2	Interleukin-10 (Interleukin 10)IBA 03/2015 - 05/2007
2	TeicoplaninIBA 06/2013 - 03/2012
2	FluoroquinolonesIBA 03/2012 - 04/2011
1	Ion Channels (Ion Channel)IBA 02/2024
1	Granzymes (Granzyme)IBA 01/2023
1	Interleukin-17 ReceptorsIBA 01/2023
1	Interleukin-12 (IL 12)IBA 01/2023
1	PerforinIBA 01/2023
1	Interleukin-17 (Interleukin 17)IBA 01/2023
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2023
1	TNF Receptor-Associated Factor 4IBA 01/2023
1	Aluminum Hydroxide (Algeldrate)FDA Link 12/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022
1	ChAdOx1 nCoV-19IBA 10/2021
1	Immunoglobulins (Immunoglobulin)IBA 10/2021
1	Heparin (Liquaemin)FDA LinkGeneric 12/2020
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 12/2020
1	Meropenem (Merrem)FDA LinkGeneric 01/2020
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020
1	remdesivirIBA 01/2020
1	Pancreatic Elastase (Elastase)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020
1	alloinIBA 11/2019
1	Antiviral Agents (Antivirals)IBA 11/2019
1	cefoperazone AIBA 01/2019
1	Cefoperazone (Cefoperazone Sodium)FDA Link 01/2019
1	CephamycinsIBA 01/2019
1	Daptomycin FDA Link 12/2018
1	Linezolid (Zyvox)FDA Link 12/2018
1	carbapenemaseIBA 04/2018
1	CPG-oligonucleotideIBA 01/2018
1	OligodeoxyribonucleotidesIBA 01/2018
1	Toll-Like Receptor 9IBA 01/2018
1	Sirolimus (Rapamycin)FDA Link 01/2017
1	InterferonsIBA 06/2016
1	AutoantibodiesIBA 06/2016
1	16S Ribosomal RNAIBA 05/2016
1	Virus ReceptorsIBA 01/2016
1	Galectins (Galectin)IBA 10/2015
1	Type II Tumor Necrosis Factor ReceptorsIBA 10/2015

Therapy/Procedure

12	Therapeutics 12/2020 - 10/2008
4	Immunotherapy 01/2018 - 05/2004
3	Duration of Therapy 12/2018 - 06/2015
1	Lasers (Laser) 12/2018
1	Artificial Respiration (Mechanical Ventilation) 10/2018
1	Intravenous Infusions 01/2018
1	Salvage Therapy 01/2017
1	Intramuscular Injections 01/2016
1	Mechanical Ventilators (Ventilator) 01/2016
1	Treatment Delay 01/2016